{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:14:33Z","timestamp":1790777673733,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ophthalmological methods have increasingly raised the interest of neuropsychiatric specialists. While the integrity of the retinal cell functions can be evaluated with the electroretinogram (ERG), optical coherence tomography (OCT) allows a structural investigation of retinal layer thicknesses. Previous studies indicate possible functional and structural retinal alterations in patients with schizophrenia. Twenty-five patients with paranoid schizophrenia and 25 healthy controls (HC) matched for age, sex, and smoking status participated in this study. Both, ERG and OCT were applied to obtain further insights into functional and structural retinal alterations. A significantly reduced a-wave amplitude and thickness of the corresponding para- and perifoveal outer nuclear layer (ONL) was detected in patients with paranoid schizophrenia with a positive correlation between both measurement parameters. Amplitude and peak time of the photopic negative response (PhNR) and thickness of the parafoveal ganglion cell layer (GCL) were decreased in patients with schizophrenia compared to HC. Our results show both structural and functional retinal differences between patients with paranoid schizophrenia and HC. We therefore recommend the comprehensive assessment of the visual system of patients with schizophrenia, especially to further investigate the effect of antipsychotic medication, the duration of illness, or other factors such as inflammatory or neurodegenerative processes. Moreover, longitudinal studies are required to investigate whether the functional alterations precede the structural changes.<\/jats:p>","DOI":"10.1038\/s41398-022-02167-7","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T05:42:47Z","timestamp":1663911767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Structural and functional retinal alterations in patients with paranoid schizophrenia"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-9656","authenticated-orcid":false,"given":"Evelyn B. N.","family":"Friedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah-Tabea","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"K\u00fcchlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0263-4360","authenticated-orcid":false,"given":"Kimon","family":"Runge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2028-535X","authenticated-orcid":false,"given":"Michael","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4906-3937","authenticated-orcid":false,"given":"Sven P.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Kornmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-1195","authenticated-orcid":false,"given":"Dominique","family":"Endres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2550-9132","authenticated-orcid":false,"given":"Katharina","family":"Domschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2274-5447","authenticated-orcid":false,"given":"Ludger","family":"Tebartz van Elst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-317X","authenticated-orcid":false,"given":"Kathrin","family":"Nickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2167_CR1","first-page":"9","volume":"42","author":"C Sch\u00f6nfeldt-Lecuona","year":"2015","unstructured":"Sch\u00f6nfeldt-Lecuona C, Kregel T, Schmidt A, Pinkhardt EH, Lauda F, Kassubek J, et al. From imaging the brain to imaging the retina: optical coherence tomography (OCT) in schizophrenia. Schizophr Bull. 2015;42:9\u201314.","journal-title":"Schizophr Bull"},{"key":"2167_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1017\/S0033291717003555","volume":"48","author":"SM Silverstein","year":"2018","unstructured":"Silverstein SM, Paterno D, Cherneski L, Green S. Optical coherence tomography indices of structural retinal pathology in schizophrenia. Psychol Med. 2018;48:2023\u201333.","journal-title":"Psychol Med"},{"key":"2167_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.scog.2015.03.004","volume":"2","author":"S Silverstein","year":"2015","unstructured":"Silverstein S, Rosen R. Schizophrenia and the eye. Schizophr Res Cogn. 2015;2:46\u201355.","journal-title":"Schizophr Res Cogn"},{"key":"2167_CR4","doi-asserted-by":"publisher","first-page":"204062232090521","DOI":"10.1177\/2040622320905215","volume":"11","author":"MT Almonte","year":"2020","unstructured":"Almonte MT, Capell\u00e0n P, Yap TE, Cordeiro MF. Retinal correlates of psychiatric disorders. Ther Adv Chronic Dis. 2020;11:2040622320905215.","journal-title":"Ther Adv Chronic Dis"},{"key":"2167_CR5","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0002-9394(03)00792-X","volume":"137","author":"GJ Jaffe","year":"2004","unstructured":"Jaffe GJ, Caprioli J. Optical coherence tomography to detect and manage retinal disease and glaucoma. Am J Ophthalmol. 2004;137:156\u201369.","journal-title":"Am J Ophthalmol"},{"key":"2167_CR6","first-page":"472790","volume":"2011","author":"S Noval","year":"2011","unstructured":"Noval S, Contreras I, Mu\u00f1oz S, Oreja-Guevara C, Manzano B, Rebolleda G. Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an update. Mult Scler Int. 2011;2011:472790.","journal-title":"Mult Scler Int"},{"key":"2167_CR7","first-page":"197","volume":"4","author":"J-Y Lee","year":"2014","unstructured":"Lee J-Y, Ahn J, Kim T, Jeon B. Optical coherence tomography in Parkinson\u2019s disease: is the retina a biomarker? J Park Dis. 2014;4:197\u2013204.","journal-title":"J Park Dis"},{"key":"2167_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","volume":"126","author":"VTT Chan","year":"2019","unstructured":"Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, et al. Spectral-Domain OCT measurements in Alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology 2019;126:497\u2013510.","journal-title":"Ophthalmology"},{"key":"2167_CR9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science 1991;254:1178\u201381.","journal-title":"Science"},{"key":"2167_CR10","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1167\/iovs.13-12534","volume":"54","author":"WW Lee","year":"2013","unstructured":"Lee WW, Tajunisah I, Sharmilla K, Peyman M, Subrayan V. Retinal nerve fiber layer structure abnormalities in schizophrenia and its relationship to disease state: evidence from optical coherence tomography. Investig Opthalmol Vis Sci. 2013;54:7785\u201392.","journal-title":"Investig Opthalmol Vis Sci"},{"key":"2167_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.psychres.2015.07.028","volume":"229","author":"FJ Ascaso","year":"2015","unstructured":"Ascaso FJ, Rodriguez-Jimenez R, Cabez\u00f3n L, L\u00f3pez-Ant\u00f3n R, Santab\u00e1rbara J, De la C\u00e1mara C, et al. Retinal nerve fiber layer and macular thickness in patients with schizophrenia: influence of recent illness episodes. Psychiatry Res. 2015;229:230\u20136.","journal-title":"Psychiatry Res"},{"key":"2167_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.eurpsy.2015.10.006","volume":"32","author":"M Celik","year":"2016","unstructured":"Celik M, Kalenderoglu A, Sevgi Karadag A, Bekir Egilmez O, Han-Almis B, \u015eim\u015fek A. Decreases in ganglion cell layer and inner plexiform layer volumes correlate better with disease severity in schizophrenia patients than retinal nerve fiber layer thickness: findings from spectral optic coherence tomography. Eur Psychiatry. 2016;32:9\u201315.","journal-title":"Eur Psychiatry"},{"key":"2167_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.5301\/ejo.5000723","volume":"26","author":"U Y\u0131lmaz","year":"2016","unstructured":"Y\u0131lmaz U, K\u00fc\u00e7\u00fck E, \u00dclgen A, \u00d6zk\u00f6se A, Demircan S, Ulusoy DM, et al. Retinal nerve fiber layer and macular thickness measurement in patients with schizophrenia. Eur J Ophthalmol. 2016;26:375\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"2167_CR14","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/schbul\/sbx130","volume":"44","author":"NN Samani","year":"2018","unstructured":"Samani NN, Proudlock FA, Siram V, Suraweera C, Hutchinson C, Nelson CP, et al. Retinal layer abnormalities as biomarkers of schizophrenia. Schizophr Bull. 2018;44:876\u201385.","journal-title":"Schizophr Bull"},{"key":"2167_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.schres.2019.03.022","volume":"219","author":"C Sch\u00f6nfeldt-Lecuona","year":"2019","unstructured":"Sch\u00f6nfeldt-Lecuona C, Kregel T, Schmidt A, Kassubek J, Dreyhaupt J, Freudenmann RW, et al. Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder. Schizophr Res. 2019;219:5\u201312.","journal-title":"Schizophr Res"},{"key":"2167_CR16","doi-asserted-by":"publisher","first-page":"109825","DOI":"10.1016\/j.pnpbp.2019.109825","volume":"98","author":"S Jerotic","year":"2020","unstructured":"Jerotic S, Ristic I, Pejovic S, Mihaljevic M, Pavlovic Z, Britvic D, et al. Retinal structural abnormalities in young adults with psychosis spectrum disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020;98:109825.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2167_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.9734\/OR\/2015\/17953","volume":"4","author":"M Mota","year":"2015","unstructured":"Mota M, P\u00eago P, Klut C, Coutinho I, Santos C, Pires G, et al. Evaluation of structural changes in the retina of patients with schizophrenia. Ophthalmol Res Int J. 2015;4:45\u201352.","journal-title":"Ophthalmol Res Int J"},{"key":"2167_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.schres.2019.10.046","volume":"219","author":"M Miller","year":"2020","unstructured":"Miller M, Zemon V, Nolan-Kenney R, Balcer LJ, Goff DC, Worthington M, et al. Optical coherence tomography of the retina in schizophrenia: Inter-device agreement and relations with perceptual function. Schizophr Res. 2020;219:13\u201318.","journal-title":"Schizophr Res"},{"key":"2167_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/24750573.2018.1426693","volume":"29","author":"P Topcu-Yilmaz","year":"2019","unstructured":"Topcu-Yilmaz P, Aydin M, Cetin, Ilhan B. Evaluation of retinal nerve fiber layer, macular, and choroidal thickness in schizophrenia: spectral optic coherence tomography findings. Psychiatry Clin Psychopharmacol. 2019;29:28\u201333.","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"2167_CR20","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1007\/s10792-021-01831-z","volume":"41","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, Rajalakshmi AR, Avudaiappan S, Eswaran S. Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia. Int Ophthalmol. 2021;41:2737\u201346.","journal-title":"Int Ophthalmol"},{"key":"2167_CR21","doi-asserted-by":"publisher","first-page":"111061","DOI":"10.1016\/j.pscychresns.2020.111061","volume":"299","author":"D Bannai","year":"2020","unstructured":"Bannai D, Lizano P, Kasetty M, Lutz O, Zeng V, Sarvode S, et al. Retinal layer abnormalities and their association with clinical and brain measures in psychotic disorders: a preliminary study. Psychiatry Res Neuroimaging. 2020;299:111061.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2167_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pscychresns.2011.08.011","volume":"203","author":"EM-Y Chu","year":"2012","unstructured":"Chu EM-Y, Kolappan M, Barnes TRE, Joyce EM, Ron MA. A window into the brain: an in vivo study of the retina in schizophrenia using optical coherence tomography. Psychiatry Res Neuroimaging. 2012;203:89\u201394.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2167_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/EB.S317186","volume":"13","author":"SM Silverstein","year":"2021","unstructured":"Silverstein SM, Lai A, Green KM, Crosta C, Fradkin SI, Ramchandran RS. Retinal microvasculature in schizophrenia. Eye Brain. 2021;13:205\u201317.","journal-title":"Eye Brain"},{"key":"2167_CR24","first-page":"1","volume":"136","author":"AG Robson","year":"2018","unstructured":"Robson AG, Nilsson J, Li S, Jalali S, Fulton AB, Tormene AP, et al. ISCEV guide to visual electrodiagnostic procedures. Doc Ophthalmol. Adv Ophthalmol. 2018;136:1\u201326.","journal-title":"Adv Ophthalmol"},{"key":"2167_CR25","unstructured":"Creel DJ. The electroretinogram and electro-oculogram: clinical applications (Part XI: Electrophysiology). Webversion Organ. Retina Vis. Syst. 2015. https:\/\/webvision.med.utah.edu\/book\/electrophysiology\/the-electroretinogram-clinical-applications\/."},{"key":"2167_CR26","doi-asserted-by":"crossref","first-page":"397178","DOI":"10.1155\/2012\/397178","volume":"2012","author":"S Machida","year":"2012","unstructured":"Machida S. Clinical applications of the photopic negative response to optic nerve and retinal diseases. J Ophthalmol. 2012;2012:397178.","journal-title":"J Ophthalmol"},{"key":"2167_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10633-018-9638-x","volume":"136","author":"L Frishman","year":"2018","unstructured":"Frishman L, Sustar M, Kremers J, McAnany JJ, Sarossy M, Tzekov R, et al. ISCEV extended protocol for the photopic negative response (PhNR) of the full-field electroretinogram. Doc Ophthalmol. 2018;136:207\u201311.","journal-title":"Doc Ophthalmol"},{"key":"2167_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eurpsy.2019.09.006","volume":"62","author":"P Youssef","year":"2019","unstructured":"Youssef P, Nath S, Chaimowitz GA, Prat SS. Electroretinography in psychiatry: a systematic literature review. Eur Psychiatry. 2019;62:97\u2013106.","journal-title":"Eur Psychiatry"},{"key":"2167_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.biopsych.2012.11.024","volume":"75","author":"J Lavoie","year":"2014","unstructured":"Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu J-M, H\u00e9bert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biol Psychiatry. 2014;75:479\u201386.","journal-title":"Biol Psychiatry"},{"key":"2167_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1388-2457(99)00223-0","volume":"111","author":"T Langheinrich","year":"2000","unstructured":"Langheinrich T, Tebartz van Elst L, Lagr\u00e8ze WA, Bach M, L\u00fccking CH, Greenlee MW. Visual contrast response functions in Parkinson\u2019s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol. 2000;111:66\u201374.","journal-title":"Clin Neurophysiol"},{"key":"2167_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","volume":"131","author":"B Nowacka","year":"2015","unstructured":"Nowacka B, Lubi\u0144ski W, Honczarenko K, Potemkowski A, Safranow K. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson\u2019s disease (PD). Doc Ophthalmol Adv Ophthalmol. 2015;131:95\u2013104.","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"2167_CR32","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/0042-6989(94)90248-8","volume":"34","author":"H Ikeda","year":"1994","unstructured":"Ikeda H, Head GM, Ellis CJ. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson\u2019s disease and a follow up study. Vis Res. 1994;34:2629\u201338.","journal-title":"Vis Res"},{"key":"2167_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.biopsych.2010.02.009","volume":"68","author":"E Bubl","year":"2010","unstructured":"Bubl E, Kern E, Ebert D, Bach M, Tebartz van Elst L. Seeing gray when feeling blue? Depression can be measured in the eye of the diseased. Biol Psychiatry. 2010;68:205\u20138.","journal-title":"Biol Psychiatry"},{"key":"2167_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1192\/bjp.bp.111.100560","volume":"201","author":"E Bubl","year":"2012","unstructured":"Bubl E, Ebert D, Kern E, van Elst LT, Bach M. Effect of antidepressive therapy on retinal contrast processing in depressive disorder. Br J Psychiatry. 2012;201:151\u20138.","journal-title":"Br J Psychiatry"},{"key":"2167_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11495-z","volume":"12","author":"KKN Tran","year":"2022","unstructured":"Tran KKN, Wong VHY, Lim JKH, Shahandeh A, Hoang A, Finkelstein DI, et al. Characterization of retinal function and structure in the MPTP murine model of Parkinson\u2019s disease. Sci Rep. 2022;12:7610.","journal-title":"Sci Rep."},{"key":"2167_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0304-3940(92)90697-6","volume":"140","author":"P Stanzione","year":"1992","unstructured":"Stanzione P, Traversa R, Pierantozzi M, Semprini R, Marciani MG, Bernardi G. An electrophysiological study of D2 dopaminergic actions in normal human retina: a tool in Parkinson\u2019s disease. Neurosci Lett. 1992;140:125\u20138.","journal-title":"Neurosci Lett"},{"key":"2167_CR37","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.pnpbp.2007.08.024","volume":"32","author":"Z Balogh","year":"2008","unstructured":"Balogh Z, Benedek G, K\u00e9ri S. Retinal dysfunctions in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:297\u2013300.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2167_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pnpbp.2013.09.020","volume":"48","author":"J Lavoie","year":"2014","unstructured":"Lavoie J, Maziade M, H\u00e9bert M. The brain through the retina: the flash electroretinogram as a tool to investigate psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:129\u201334.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2167_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.biopsych.2019.06.014","volume":"87","author":"M H\u00e9bert","year":"2020","unstructured":"H\u00e9bert M, M\u00e9rette C, Gagn\u00e9 A-M, Paccalet T, Moreau I, Lavoie J, et al. The electroretinogram may differentiate schizophrenia from bipolar disorder. Biol Psychiatry. 2020;87:263\u201370.","journal-title":"Biol Psychiatry"},{"key":"2167_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1037\/abn0000347","volume":"127","author":"DL Demmin","year":"2018","unstructured":"Demmin DL, Davis Q, Roch\u00e9 M, Silverstein SM. Electroretinographic anomalies in schizophrenia. J Abnorm Psychol. 2018;127:417\u201328.","journal-title":"J Abnorm Psychol"},{"key":"2167_CR41","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0006-3223(98)00379-5","volume":"45","author":"R Warner","year":"1999","unstructured":"Warner R, Laugharne J, Peet M, Brown L, Rogers N. Retinal function as a marker for cell membrane omega\u20133 fatty acid depletion in schizophrenia: a pilot study. Biol Psychiatry. 1999;45:1138\u201342.","journal-title":"Biol Psychiatry"},{"key":"2167_CR42","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.schres.2014.12.030","volume":"162","author":"M H\u00e9bert","year":"2015","unstructured":"H\u00e9bert M, M\u00e9rette C, Paccalet T, \u00c9mond C, Gagn\u00e9 A-M, Sasseville A, et al. Light evoked potentials measured by electroretinogram may tap into the neurodevelopmental roots of schizophrenia. Schizophr Res. 2015;162:294\u2013305.","journal-title":"Schizophr Res"},{"key":"2167_CR43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.schres.2019.07.007","volume":"219","author":"F Bernardin","year":"2020","unstructured":"Bernardin F, Schwitzer T, Angioi-Duprez K, Giersch A, Jansen C, Schwan R, et al. Retinal ganglion cells dysfunctions in schizophrenia patients with or without visual hallucinations. Schizophr Res. 2020;219:47\u201355.","journal-title":"Schizophr Res"},{"key":"2167_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.schres.2019.09.005","volume":"219","author":"P Moghimi","year":"2020","unstructured":"Moghimi P, Torres Jimenez N, McLoon LK, Netoff TI, Lee MS, MacDonald A, et al. Electoretinographic evidence of retinal ganglion cell-dependent function in schizophrenia. Schizophr Res. 2020;219:34\u201346.","journal-title":"Schizophr Res"},{"key":"2167_CR45","first-page":"729","volume":"59","author":"D Durakovi\u0107","year":"2020","unstructured":"Durakovi\u0107 D, Sili\u0107 A, Peitl V, Tadi\u0107 R, Lon\u010dari\u0107 K, Glavina T, et al. The use of electroretinography and optical coherence tomography in patients with schizophrenia. Acta Clin Croat. 2020;59:729\u201338.","journal-title":"Acta Clin Croat"},{"key":"2167_CR46","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261\u201376.","journal-title":"Schizophr Bull"},{"key":"2167_CR47","unstructured":"Sa\u00df H, Wittchen H-U, Zaudig M, Houben I. Diagnostisches und statistisches Manual psychischer St\u00f6rungen DSM-IV-TR. G\u00f6ttingen: Hogrefe; 2003."},{"key":"2167_CR48","unstructured":"Derogatis LR, Savitz KL. The SCL-90-R, Brief symptom inventory, and matching clinical rating scales. In: The use of psychological testing for treatment planning and outcomes assessment, 2nd ed. Mahwah: Lawrence Erlbaum Associates Publishers; 1999. pp 679\u2013724."},{"key":"2167_CR49","unstructured":"Hautzinger M, Keller F, K\u00fchner C. Beck Depressions-Inventar: BDI II. Revision. In: Deutsche Bearbeitung von Beck, A. T., Steer, R. A., Brown, G. K. Beck Depression Inventory\u2013II (BDI\u2013II). Frankfurt am Main: Harcourt Test Services; 2006."},{"key":"2167_CR50","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","volume":"67","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess. 1996;67:588\u201397.","journal-title":"J Pers Assess"},{"key":"2167_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10633-010-9240-3","volume":"121","author":"A Al Abdlseaed","year":"2010","unstructured":"Al Abdlseaed A, McTaggart Y, Ramage T, Hamilton R, McCulloch DL. Light- and dark-adapted electroretinograms (ERGs) and ocular pigmentation: comparison of brown- and blue-eyed cohorts. Doc Ophthalmol Adv Ophthalmol. 2010;121:135\u201346.","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"2167_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10633-018-9652-z","volume":"137","author":"AE Hobby","year":"2018","unstructured":"Hobby AE, Kozareva D, Yonova-Doing E, Hossain IT, Katta M, Huntjens B, et al. Effect of varying skin surface electrode position on electroretinogram responses recorded using a handheld stimulating and recording system. Doc Ophthalmol. 2018;137:79\u201386.","journal-title":"Doc Ophthalmol"},{"key":"2167_CR53","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1167\/iovs.12-11201","volume":"54","author":"D Preiser","year":"2013","unstructured":"Preiser D, Lagr\u00e8ze WA, Bach M, Poloschek CM. Photopic Negative Response versus pattern electroretinogram in early glaucoma. Invest Ophthalmol Vis Sci. 2013;54:1182\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2167_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10633-010-9239-9","volume":"121","author":"KE Mortlock","year":"2010","unstructured":"Mortlock KE, Binns AM, Aldebasi YH, North RV. Inter-subject, inter-ocular and inter-session repeatability of the photopic negative response of the electroretinogram recorded using DTL and skin electrodes. Doc Ophthalmol. 2010;121:123\u201334.","journal-title":"Doc Ophthalmol"},{"key":"2167_CR55","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/S0161-6420(00)00284-0","volume":"107","author":"DF Garway-Heath","year":"2000","unstructured":"Garway-Heath DF, Poinoosawmy D, Fitzke FW, Hitchings RA. Mapping the visual field to the optic disc in normal tension glaucoma eyes. Ophthalmology. 2000;107:1809\u201315.","journal-title":"Ophthalmology."},{"key":"2167_CR56","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","volume":"114","author":"EY Chew","year":"1996","unstructured":"Chew EY. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996;114:1079.","journal-title":"Arch Ophthalmol"},{"key":"2167_CR57","volume-title":"R: A language and environment for statistical computing","author":"R Core Team.","year":"2021","unstructured":"R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing;; 2021. https:\/\/www.R-project.org\/"},{"key":"2167_CR58","volume-title":"RStudio: Integrated development environment for R. RStudio","author":"RStudio Team.","year":"2020","unstructured":"RStudio Team. RStudio: Integrated development environment for R. RStudio. Boston: PBC;; 2020. http:\/\/www.rstudio.com\/"},{"key":"2167_CR59","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LD, Fran\u00e7ois R, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:1686.","journal-title":"J Open Source Softw"},{"key":"2167_CR60","unstructured":"Kassambara A. ggpubr: \u2018ggplot2\u2019 based publication ready plots. 2020. https:\/\/CRAN.R-project.org\/package=ggpubr."},{"key":"2167_CR61","first-page":"65","volume":"6","author":"S Holm","year":"1979","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65\u201370.","journal-title":"Scand J Stat"},{"key":"2167_CR62","unstructured":"Kassambara A. rstatix: Pipe-friendly framework for basic statistical tests. 2021. https:\/\/CRAN.R-project.org\/package=rstatix."},{"key":"2167_CR63","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen J. A power primer. Psychol Bull. 1992;112:155\u20139.","journal-title":"Psychol Bull"},{"key":"2167_CR64","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.21105\/joss.02306","volume":"5","author":"D Makowski","year":"2020","unstructured":"Makowski D, Ben-Shachar M, Patil I, L\u00fcdecke D. Methods and algorithms for correlation analysis in R. J Open Source Softw. 2020;5:2306.","journal-title":"J Open Source Softw"},{"key":"2167_CR65","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner DM, Murphy AL, O\u2019Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167:686\u201393.","journal-title":"Am J Psychiatry"},{"key":"2167_CR66","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/0042-6989(81)90013-4","volume":"21","author":"H Kolb","year":"1981","unstructured":"Kolb H, Nelson R, Mariani A. Amacrine cells, bipolar cells and ganglion cells of the cat retina: a Golgi study. Vis Res. 1981;21:1081\u2013114.","journal-title":"Vis Res"},{"key":"2167_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/archopht.122.3.341","volume":"122","author":"Y Gotoh","year":"2004","unstructured":"Gotoh Y. Selective loss of the Photopic Negative Response in patients with optic nerve atrophy. Arch Ophthalmol. 2004;122:341.","journal-title":"Arch Ophthalmol"},{"key":"2167_CR68","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ophtha.2015.11.009","volume":"123","author":"PJ Patel","year":"2016","unstructured":"Patel PJ, Foster PJ, Grossi CM, Keane PA, Ko F, Lotery A, et al. Spectral-Domain Optical coherence tomography imaging in 67 321 adults. Ophthalmology. 2016;123:829\u201340.","journal-title":"Ophthalmology."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02167-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T04:55:08Z","timestamp":1676868908000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2167"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02167-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"assertion":[{"value":"24 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KD: member of the \u2018Steering Committee Neurosciences\u2019, Janssen Pharmaceuticals, Inc., LTvE: Advisory boards, lectures, or travel grants within the last 3 years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}